Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
5.86
-0.19 (-3.14%)
At close: Dec 20, 2024, 4:00 PM
5.80
-0.06 (-1.02%)
After-hours: Dec 20, 2024, 7:58 PM EST
Terns Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | - | - | - | 1 | - | - | |
| Gross Profit | - | - | - | 1 | - | - | |
| Selling, General & Admin | 30.41 | 39.06 | 22.41 | 19.55 | 9 | 8.66 | |
| Research & Development | 69.57 | 63.5 | 39.62 | 31.31 | 28.03 | 26.53 | |
| Operating Expenses | 99.98 | 102.56 | 62.03 | 50.86 | 37.03 | 35.2 | |
| Operating Income | -99.98 | -102.56 | -62.03 | -49.86 | -37.03 | -35.2 | |
| Interest & Investment Income | 12.48 | 12.9 | 2.11 | 0.17 | 0.06 | 1.2 | |
| Other Non Operating Income (Expenses) | -0.3 | -0.31 | -0.07 | 0.04 | 0.1 | 0.15 | |
| EBT Excluding Unusual Items | -87.8 | -89.97 | -59.99 | -49.65 | -36.87 | -33.84 | |
| Other Unusual Items | - | - | - | - | 7.81 | -35 | |
| Pretax Income | -87.8 | -89.97 | -59.99 | -49.65 | -29.06 | -68.84 | |
| Income Tax Expense | 0.27 | 0.24 | 0.36 | 0.51 | 0.81 | -0.02 | |
| Earnings From Continuing Operations | -88.07 | -90.21 | -60.35 | -50.16 | -29.87 | -68.82 | |
| Minority Interest in Earnings | - | - | - | - | 0.52 | 0.21 | |
| Net Income | -88.07 | -90.21 | -60.35 | -50.16 | -29.35 | -68.61 | |
| Net Income to Common | -88.07 | -90.21 | -60.35 | -50.16 | -29.35 | -68.61 | |
| Shares Outstanding (Basic) | 75 | 71 | 36 | 23 | 0 | 0 | |
| Shares Outstanding (Diluted) | 75 | 71 | 36 | 23 | 0 | 0 | |
| Shares Change (YoY) | 11.75% | 97.76% | 58.69% | 7862.47% | 55.60% | 145.81% | |
| EPS (Basic) | -1.18 | -1.27 | -1.67 | -2.21 | -102.93 | -374.39 | |
| EPS (Diluted) | -1.18 | -1.27 | -1.67 | -2.21 | -102.93 | -374.39 | |
| Free Cash Flow | -74.83 | -67.44 | -49.38 | -42.17 | -30.39 | -67.12 | |
| Free Cash Flow Per Share | -1.00 | -0.95 | -1.37 | -1.86 | -106.58 | -366.26 | |
| Gross Margin | - | - | - | 100.00% | - | - | |
| Operating Margin | - | - | - | -4986.00% | - | - | |
| Profit Margin | - | - | - | -5015.80% | - | - | |
| Free Cash Flow Margin | - | - | - | -4216.70% | - | - | |
| EBITDA | -99.66 | -102.27 | -61.55 | -49.35 | -36.63 | -35 | |
| D&A For EBITDA | 0.33 | 0.29 | 0.48 | 0.51 | 0.39 | 0.2 | |
| EBIT | -99.98 | -102.56 | -62.03 | -49.86 | -37.03 | -35.2 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.